Vai al contenuto principale


Analisi finanziarie e report  a supporto della clientela istituzionale e corporate nelle decisioni di investimento.

2024 M02 15

FY 23 results met guidance and FY 24 guidance in line with previous outlook

2024 M01 11

Post-integration of Luminex, Diasorin plots new growth pathways

2023 M12 11

AWEsomely poised to spark the hydrogen transition

2023 M07 04

Sound business model

2023 M06 08

Italian omnichannel betting champion with significant growth upside

2023 M06 07

Q1 confirmed the strong 2023 guidance, waiting for the plan update

Banca Akros